Bitcoin

Defiance

Blockstream CEO <a href="https://coingape.com/bitcoin-btc-price-to-ath-adam-back-shares-optimistic-timeline/" rel="noopener noreferrer nofollow">Adam Back</a> has publicly blasted the Defiance 2X Short MSTR ETF. He labeled the product “awful” and then questioned its longevity. The ETF wants to short MicroStrategy Incorporated, which has substantial Bitcoin portfolios. Back’s greatest problem would be the inherent threat of the ETF technique, particularly with Bitcoin so volatile and so highly linked with MicroStrategy’s stock.
The second-biggest Bitcoin owner is <a href="https://coingape.com/michael-saylor-microstrategy-holds-more-bitcoin-us-china-govt/" rel="noopener noreferrer nofollow">MicroStrategy</a>, which has more than 210,000 BTC. The ETF, which monitors the company’s shares to shorten, has sparked discussion. Adam Back discusses the hazards of shorting an asset whose price action is related to Bitcoin’s value patterns. He claims the plan could cause substantial losses, “especially when Bitcoin rose in value.”
<h2 id="strong-adam-back-warns-against-new-mstr-etf-strong">Adam Back Warns Against New MSTR ETF</h2>
The Defiance 2X short <a href="https://coingape.com/crypto-stocks/mstr/" rel="noopener noreferrer nofollow">MSTR</a> ETF utilizes auto rebalancing and doubles down on Short positions. However, Adam Back details the dangers of this type of strategy in an uncertain market. He claims that if the <a href="https://coingape.com/price/bitcoin/#:~:text=Live%20Price%20of%20Bitcoin%20(BTC,market%20cap%20stands%20at%20%241%2C365%2C115%2C790%2C113." rel="noopener noreferrer nofollow">Bitcoin price</a> doubles, the ETF will get caught out of it and experience huge losses. This particular situation demonstrates the difficulty of controlling portfolios with correlated, very volatile underlying assets.
Back continues by explaining that auto rebalancing in these kinds of scenarios could degrade capital. He asserts the ETF’s structure might be too opaque for the volatile nature of Bitcoin and its effect on MicroStrategy’s share price. It’s feared that investors will take increased chances with no anticipated returns—a question mark with the ETF’s approach.
<h2 id="strong-microstrategy-at-the-forefront-of-crypto-investment-strong">MicroStrategy at the Forefront of Crypto Investment</h2>
MicroStrategy is renowned for its intense Bitcoin investing strategy. Some think the company’s shares are overpriced at&nbsp; $1,631 with a $24.42 billion market cap. However, the enormous returns from Bitcoin investments have drawn investors seeking Bitcoin coverage in the former stock markets.
Chairman <a href="https://coingape.com/michael-saylor-stays-positive-on-bitcoin-places-it-above-microstrategy-shares/" rel="noopener noreferrer nofollow">Michael Saylor </a>remains committed to Bitcoin, reinforcing the company’s long-term strategy despite criticisms. This stance, along with the company’s performance, has made MicroStrategy a notable player in the intersection of corporate investment and cryptocurrency.
Read Also: <a href="https://coingape.com/do-kwon-us-prosecution-gains-solid-grounds-sequel-to-montenegro-ruling/" rel="noopener noreferrer nofollow">Do Kwon’s US Prosecution Gains Solid Grounds Sequel to Montenegro Ruling</a>
The post <a href="https://coingape.com/adam-back-criticizes-new-etf-targeting-microstrategy/" rel="noopener noreferrer nofollow">Adam Back Criticizes New ETF Targeting MicroStrategy</a> appeared first on <a href="https://coingape.com" rel="noopener noreferrer nofollow">CoinGape</a>.

Adam Back Criticizes New ETF Targeting MicroStrategy

Table of Contents

Coingape News Media

Other articles published on Apr 8, 2024

Solana, Base account for most DEX listings amid meme coin craze

New AI Hub to Spearhead Language Model Innovation Set by Microsoft in London

KLC holds strong in the April meme coin scene alongside PEPE, WIF

Livepeer Price Prediction for Today, April 8 – LPT Technical Analysis

Metaplanet Collaborate with Prominent Investors to Embrace Bitcoin

WHO Unveils Ethical Framework to Govern AI’s Role in Pharmaceutical Development

Join our free newsletter for daily crypto updates!